Specificity of anti-PRA and anti-PRB antibodies was examined using T47D breast cancer cells that express no PR (T47D-Y), PRA only (T47D-YA), PRB only (T47D-YB), or both PRA and PRB (T47D). Here, RB1 is linked to breast carcinoma.